A Prospective, Observational Study of Individuals Who Seroconvert While Taking Truvada for Pre-Exposure Prophylaxis (PrEP)
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 17 Apr 2019
Price : $35 *
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors Gilead Sciences
- 12 Apr 2019 Status changed from recruiting to active, no longer recruiting.
- 05 Feb 2019 Planned End Date changed from 1 Sep 2019 to 1 Mar 2020.
- 05 Feb 2019 Planned primary completion date changed from 1 Sep 2019 to 1 Mar 2019.